<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05001594</url>
  </required_header>
  <id_info>
    <org_study_id>0089-21-RMB</org_study_id>
    <nct_id>NCT05001594</nct_id>
  </id_info>
  <brief_title>Wearable Vibration Effect on Biomechanics and Biomarkers After ACL Reconstruction</brief_title>
  <official_title>The Effects of a Wearable Vibratory Device on Biomechanics, Quality of Life and Serum Biomarkers After an ACL Reconstruction Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technion, Israel Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Technion, Israel Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anterior cruciate ligament (ACL) injuries account for up to 25% of knee injuries, it is&#xD;
      estimated that 32,000-400,000 new cases of ACL tears occur in the USA every year.&#xD;
&#xD;
      The Standard care is twofold; a) ACL reconstruction surgery and b) prolonged rehabilitation&#xD;
      period (usually no less than 9 months). However, only a big proportion of patients do not&#xD;
      return to their pre-injury activity level, and up to 30% reinjure their ACL in the following&#xD;
      two years.&#xD;
&#xD;
      The wearable system consists of two non-invasive bands, above and below the knee that vibrate&#xD;
      during the weight bearing phase while walking.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to investigate the effect of treatment for ACL reconstruction,&#xD;
      including vibrational stimulation and pressure, on locomotion tasks (i.e. walking, stair&#xD;
      ascending and descending), muscle function, and pain/function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lower limb joints range of motion (Degrees)</measure>
    <time_frame>Pre-surgery</time_frame>
    <description>Measured by Inertial measurement unit system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lower limb joints range of motion (Degrees)</measure>
    <time_frame>14 days post op</time_frame>
    <description>Measured by Inertial measurement unit system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lower limb joints range of motion (Degrees)</measure>
    <time_frame>2 months post op</time_frame>
    <description>Measured by Inertial measurement unit system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lower limb joints range of motion (Degrees)</measure>
    <time_frame>4 months post op</time_frame>
    <description>Measured by Inertial measurement unit system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lower limb joints range of motion (Degrees)</measure>
    <time_frame>6 months post op</time_frame>
    <description>Measured by Inertial measurement unit system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee strength (Newtons)</measure>
    <time_frame>Pre-surgery</time_frame>
    <description>Non injured knee, quadriceps and hamstring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee strength (Newtons)</measure>
    <time_frame>14 days post op</time_frame>
    <description>Non injured knee, quadriceps and hamstring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee strength (Newtons)</measure>
    <time_frame>2 months post op</time_frame>
    <description>Non injured knee, quadriceps and hamstring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee strength (Newtons)</measure>
    <time_frame>4 months post op</time_frame>
    <description>Non injured knee, quadriceps and hamstring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee strength (Newtons)</measure>
    <time_frame>6 months post op</time_frame>
    <description>Non injured knee, quadriceps and hamstring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee strength (Newtons)</measure>
    <time_frame>Pre-surgery</time_frame>
    <description>Injured knee, quadriceps and hamstring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee strength (Newtons)</measure>
    <time_frame>4 months post op</time_frame>
    <description>Injured knee, quadriceps and hamstring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee strength (Newtons)</measure>
    <time_frame>6 months post op</time_frame>
    <description>Injured knee, quadriceps and hamstring</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The International Knee Documentation Committee (IKDC) Subjective Knee Form</measure>
    <time_frame>Pre-surgery</time_frame>
    <description>The IKDC total score ranges from 0 to 100, where 100 indicates the highest levels of function and lowest levels of symptoms and 0 indicates the lowest level of function or highest level of symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The International Knee Documentation Committee (IKDC) Subjective Knee Form</measure>
    <time_frame>14 days post op</time_frame>
    <description>The IKDC total score ranges from 0 to 100, where 100 indicates the highest levels of function and lowest levels of symptoms and 0 indicates the lowest level of function or highest level of symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The International Knee Documentation Committee (IKDC) Subjective Knee Form</measure>
    <time_frame>2 months post op</time_frame>
    <description>The IKDC total score ranges from 0 to 100, where 100 indicates the highest levels of function and lowest levels of symptoms and 0 indicates the lowest level of function or highest level of symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The International Knee Documentation Committee (IKDC) Subjective Knee Form</measure>
    <time_frame>4 months post op</time_frame>
    <description>The IKDC total score ranges from 0 to 100, where 100 indicates the highest levels of function and lowest levels of symptoms and 0 indicates the lowest level of function or highest level of symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The International Knee Documentation Committee (IKDC) Subjective Knee Form</measure>
    <time_frame>6 months post op</time_frame>
    <description>The IKDC total score ranges from 0 to 100, where 100 indicates the highest levels of function and lowest levels of symptoms and 0 indicates the lowest level of function or highest level of symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>General Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>Pre-surgery</time_frame>
    <description>The GAD-7 total score ranges from 0 to 21, where 21 represents high anxiety and 0 indicates no anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>General Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>14 days post op</time_frame>
    <description>The GAD-7 total score ranges from 0 to 21, where 21 represents high anxiety and 0 indicates no anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>General Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>2 months post op</time_frame>
    <description>The GAD-7 total score ranges from 0 to 21, where 21 represents high anxiety and 0 indicates no anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>General Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>4 months post op</time_frame>
    <description>The GAD-7 total score ranges from 0 to 21, where 21 represents high anxiety and 0 indicates no anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>General Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>6 months post op</time_frame>
    <description>The GAD-7 total score ranges from 0 to 21, where 21 represents high anxiety and 0 indicates no anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tampa Scale of Kinesiophobia (TSK)</measure>
    <time_frame>Pre-surgery</time_frame>
    <description>The TSK total score ranges from 17 to 68, where 68 represents high kinesiophobia and 17 indicates no kinesiophobia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tampa Scale of Kinesiophobia (TSK)</measure>
    <time_frame>14 days post op</time_frame>
    <description>The TSK total score ranges from 17 to 68, where 68 represents high kinesiophobia and 17 indicates no kinesiophobia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tampa Scale of Kinesiophobia (TSK)</measure>
    <time_frame>2 months post op</time_frame>
    <description>The TSK total score ranges from 17 to 68, where 68 represents high kinesiophobia and 17 indicates no kinesiophobia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tampa Scale of Kinesiophobia (TSK)</measure>
    <time_frame>4 months post op</time_frame>
    <description>The TSK total score ranges from 17 to 68, where 68 represents high kinesiophobia and 17 indicates no kinesiophobia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tampa Scale of Kinesiophobia (TSK)</measure>
    <time_frame>6 months post op</time_frame>
    <description>The TSK total score ranges from 17 to 68, where 68 represents high kinesiophobia and 17 indicates no kinesiophobia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Single-leg hop for distance (cm)</measure>
    <time_frame>4 months post op</time_frame>
    <description>Functional assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single-leg hop for distance (cm)</measure>
    <time_frame>6 months post op</time_frame>
    <description>Functional assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single-leg drop jump (cm)</measure>
    <time_frame>4 months post op, 6 months post op</time_frame>
    <description>Functional assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single-leg drop jump (cm)</measure>
    <time_frame>6 months post op</time_frame>
    <description>Functional assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Biomarkers (ng/mL)</measure>
    <time_frame>2 months post op</time_frame>
    <description>30-minute walk on a treadmill. change in concertation before and after the walk</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Anterior Cruciate Ligament Injuries</condition>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Each participant will go through the normal rehabilitation process that follows ACL reconstruction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care+ knee vibratory device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant will go through the normal rehabilitation process that follows ACL reconstruction. Additionally, each participant will receive the active device that applies non-invasive vibrational stimulation to the leg for two months, and will be asked to wear it during ambulation for at least an hour per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active vibratory knee device</intervention_name>
    <description>The active, wearable device is placed above and below the knee joint. The device consists of a sensing module to determine specific points in the gait cycle, a processor to analyze signal from the sensor, and a stimulus module to provide vibratory feedback to the subject.</description>
    <arm_group_label>Usual care+ knee vibratory device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Provision of signed and dated informed consent form&#xD;
&#xD;
          -  Males and females&#xD;
&#xD;
          -  Aged 18-50&#xD;
&#xD;
          -  Scheduled for an ACL reconstruction in Rambam hospital.&#xD;
&#xD;
          -  Hebrew language at mother tongue level&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to understand the study protocol.&#xD;
&#xD;
          -  Known neuropathies, active cancer, previous fractures in the lower limbs, inflammatory&#xD;
             arthritis, implanted electronic devices of any kind.&#xD;
&#xD;
          -  Allergies to silver or adhesives.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arielle Fischer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Technion, Israel Institute of Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bezalel Peskin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tomer Yona, M.Sc</last_name>
    <phone>972547841186</phone>
    <email>tomeryona@campus.technion.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam Health Care Campus</name>
      <address>
        <city>Haifa</city>
        <zip>3109601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <contact>
      <last_name>Tomer Yona, MSc</last_name>
      <email>tomeryona@campus.technion.ac.il</email>
    </contact>
    <investigator>
      <last_name>Bezalel Peskin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 22, 2021</study_first_submitted>
  <study_first_submitted_qc>August 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Technion, Israel Institute of Technology</investigator_affiliation>
    <investigator_full_name>Arielle Fischer</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Knee pathology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anterior Cruciate Ligament Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

